Legal Representation
Attorney
Lisa M. Martens, Christopher S. Marchese, Scott C. Harris, Gregory M. Krakau, John A. Mizhir Jr., Desa L. Burton, Andrew M. Abrams, Timothy A. French
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 9, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 9, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 30, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 6, 2006 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 6, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2006 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Aug 29, 2006 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 29, 2006 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 19, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 19, 2005 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 19, 2005 | I | PAPER RECEIVED | Loading... | |
| Sep 6, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 26, 2005 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| May 17, 2005 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | Loading... |
| Apr 11, 2005 | I | PAPER RECEIVED | Loading... | |
| Mar 2, 2005 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Feb 22, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 2, 2005 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Dec 17, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 17, 2004 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 8, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 8, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 19, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical product, namely, an antigrowth factor targeted immunotherapeutic drug, excluding veterinary preparations and substances
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005